ACEI or ARB therapy prescribed to four out of five patients with acute coronary syndrome
(dailyRx News) ACEIs and ARBs are medications that help lower the risk of death in high-risk patients who have had a heart attack. But many of these high-risk patients may not be getting these beneficial medications.
A recent study by the American Heart Association investigated whether hospital patients with acute coronary syndrome were receiving ACEI or ARB prescriptions before being discharged.
The researchers found that one in five eligible patients did not receive a prescription.
The authors of this study suggested that some patients who could benefit from ACEIs or ARBs may not be receiving the medication.
Read more from RxWiki HERE.